PRAME and metastatic melanoma: Though these studies suggest a strong correlation between PRAME positivity and poorer prognosis, an analysis by Parra et al. found no significant difference between PRAME expression in primary cutaneous versus metastatic melanoma; this is not surprising, as PRAME levels would be expected to remain high whether or not we are looking at primary melanoma or metastatic cells [48].